![Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-021-01260-7/MediaObjects/12874_2021_1260_Fig3_HTML.png)
Intention-to-treat analysis may be more conservative than per protocol analysis in antibiotic non-inferiority trials: a systematic review | BMC Medical Research Methodology | Full Text
![On Biostatistics and Clinical Trials: Protocol Deviations - How is the Protocol Deviation Data Analyzed and Used? On Biostatistics and Clinical Trials: Protocol Deviations - How is the Protocol Deviation Data Analyzed and Used?](https://lh3.googleusercontent.com/-S8SZiceklq8/YWt3lo-J_GI/AAAAAAAAEAY/ivk8ZO_fcA8nAMAUQMop5FUNnhgPIjYcQCLcBGAsYHQ/w581-h594/image.png)
On Biostatistics and Clinical Trials: Protocol Deviations - How is the Protocol Deviation Data Analyzed and Used?
![Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population](https://www.signifience.com/wp-content/uploads/2022/10/Groupe_people_01_01S-scaled-e1672600105362.jpg)
Signifience - Intention-to-Treat (ITT) vs. Per Protocol (PP) : How to choose the right clinical trial population
![Trial profile. Population: ITT = intention-to-treat, PP = per protocol. | Download Scientific Diagram Trial profile. Population: ITT = intention-to-treat, PP = per protocol. | Download Scientific Diagram](https://www.researchgate.net/publication/322154218/figure/fig2/AS:991448019243010@1613391036225/Trial-profile-Population-ITT-intention-to-treat-PP-per-protocol.png)
Trial profile. Population: ITT = intention-to-treat, PP = per protocol. | Download Scientific Diagram
![Figure 2, Forest Plot For ACR20 Responses at Week 24 in SUMMACTA and MUSASHI Studies for the Per-Protocol Population - Tocilizumab (Actemra) - NCBI Bookshelf Figure 2, Forest Plot For ACR20 Responses at Week 24 in SUMMACTA and MUSASHI Studies for the Per-Protocol Population - Tocilizumab (Actemra) - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK349502/bin/sr0374f2.jpg)
Figure 2, Forest Plot For ACR20 Responses at Week 24 in SUMMACTA and MUSASHI Studies for the Per-Protocol Population - Tocilizumab (Actemra) - NCBI Bookshelf
![Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - eBioMedicine Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - eBioMedicine](https://www.thelancet.com/cms/asset/f4c037b3-88ba-4db0-af7f-47d59391fb08/gr1.jpg)
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial - eBioMedicine
Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites | PLOS Medicine
![Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1472-6939-15-28/MediaObjects/12910_2014_Article_268_Fig1_HTML.jpg)
Screening: the information individuals need to support their decision: per protocol analysis is better than intention-to-treat analysis at quantifying potential benefits and harms of screening | BMC Medical Ethics | Full Text
![Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults | Scientific Reports Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-48554-x/MediaObjects/41598_2019_48554_Fig1_HTML.png)